Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery

Neuropathology

Volumn 23, Issue 1, 2003, Pages 1-8

  Kuroda, Satoshi ^a   Kobayashi, Tohru ^a   Ishii, Nobuaki ^a   Ikeda, Jun ^a   Shinohe, Yumiko ^a   Houkin, Kiyohiro ^a   Iwasaki, Yoshinobu ^a   Nagashima, Kazuo ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Carotid artery; Chlamydia pneumoniae; Endarterectomy; Heat shock protein; Macrophage

Indexed keywords

BACTERIAL ANTIGEN; HEAT SHOCK PROTEIN 60;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; ATHEROMA; ATHEROMATOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTIMA; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER;

AGED; ARTERIOSCLEROSIS; CAROTID STENOSIS; CHAPERONIN 60; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENDOTHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH;

EID: 0037357198     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2003.00484.x     Document Type: Article

References (37)

1. de Boer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation and infection. J Pathol 2000; 190: 237-243.
2. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315: 161-168.
3. Cook PJ, Honeybourne D. Chlamydia pneumoniae. J Antimicrob Chemother 1994; 34: 859-873.
4. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gammamediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90: 3998-4002.
5. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25 (Suppl. 1): 27-34.
6. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
7. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158-161.
8. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13: 1501-1504.
9. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
10. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 1996; 125: 979-982.
11. Ross R. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant Proc 1993; 25: 2041-2043.
12. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98: 300-307.
13. Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery. Stroke 1998; 29: 773-778.
14. Grayston JT, Kuo CC, Coulson AS et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-3400.
15. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144-2148.
16. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997; 176: 292-295.
17. Mosorin M, Surcel HM, Laurila A et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 2000; 20: 1061-1067.
18. Maass M, Krause E, Engel PM, Kruger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997; 48: 699-706.
19. Esposito G, Blasi F, Allegra L et al. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg 1999; 13: 421-425.
20. Gibbs RG, Sian M, Mitchell AW, Greenhalgh RM, Davies AH, Carey N. Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis. Stroke 2000; 31: 2930-2935.
21. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71: 1554-1560.
22. Dobrilovic N, Vadlamani L, Meyer M, Wright CB. Chlamydia pneumoniae in atherosclerotic carotid artery plaques: High prevalence among heavy smokers. Am Surg 2001; 67: 589-593.
23. Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 2001; 32: 2748-2752.
24. LaBiche R, Koziol D, Quinn TC et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-860.
25. Ong GM, Coyle PV, Barros D'Sa AA et al. Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis 2001; 1: 12.
26. Valassina M, Migliorini L, Sansoni A et al. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. J Med Microbiol 2001; 50: 228-232.
27. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis: What we know and what we don't. Clin Microbiol Infect 2002; 8: 2-13.
28. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64:1614-1620.
29. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-1325.
30. Kaul R, Wenman WM. Chlamydia pneumoniae facilitates monocyte adhesion to endothelial and smooth muscle cells. Microb Pathog 2001; 30: 149-155.
31. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177: 725-729.
32. LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: New paradigms for old problems? Infect Dis Obstet Gynecol 1999; 7: 64-71.
33. Halme S, Saikku P, Surcel HM. Characterization of Chlamydia pneumoniae antigens using human T cell clones. Scand J Immunol 1997; 45: 378-384.
34. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of lowdensity lipoprotein by Chlamydia pneumoniae. J Infect Dis 1999; 180: 780-790.
35. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995; 92: 3893-3897.
36. Sasu S, LaVerda D, Qureshi N, Golenbock DT, Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001; 89: 244-250.
37. Mayr M, Metzler B, Kiechl S et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999; 99: 1560-1566.